Advanced in Thrombocytopenia
Advanced in Thrombocytopenia

Overview

Samuel Kerr is a Hematologist and an Oncologist in Lancaster, Pennsylvania. Dr. Kerr is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Non-Small Cell Lung Cancer (NSCLC). Dr. Kerr is currently accepting new patients.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Temple University School Of Medicine
Residency
Penn State Milton S. Hershey Medical Center
Specialties
Hematology
Oncology
Licenses
Internal Medicine in PA
Board Certifications
Hematology, 2006
Medical Oncology, 2005
Internal Medicine, 2002
Fellowships
Penn State Milton S. Hershey Medical Center
Hospital Affiliations
Lancaster General Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

LG Health Physicians Hematology and Medical Oncology
2102 Harrisburg Pike, Lancaster, PA 17601

Additional Areas of Focus

Dr. Kerr has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Pernicious Anemia
Thalassemia
Lung Cancer
Bladder Cancer
Thyroid Cancer
Colorectal Cancer
Testicular Cancer
Breast Cancer
Burkitt Lymphoma
Sickle Cell Disease
Pancreatic Cancer
Dyskeratosis Congenita
Anal Cancer
Iron Deficiency Anemia
Multiple Myeloma
Cryoglobulinemia
Esophageal Cancer
Myelofibrosis
Anemia
Hodgkin Lymphoma
Waldenstrom Macroglobulinemia
Liver Cancer
Prostate Cancer
Beta Thalassemia
Gallbladder Cancer
Blood Clots
Autoimmune Hemolytic Anemia
View 17 Less Areas of Focus-

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Clinical Trials

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Similar Doctors
Elite in Thrombocytopenia
Hematology
Elite in Thrombocytopenia
Hematology

University Of Penn - Medical Group

3400 Spruce St, Department Of Pathology And, 
Philadelphia, PA 
 (62.1 miles away)
Languages Spoken:
English

Adam Cuker is a Hematologist in Philadelphia, Pennsylvania. Dr. Cuker is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Splenectomy, and Knee Replacement.

Elite in Thrombocytopenia
Elite in Thrombocytopenia

University Of Penn - Medical Group

3400 Spruce St, Department Of Pathology And, 
Philadelphia, PA 
 (62.1 miles away)
Languages Spoken:
English

Douglas Cines is a Hematologist in Philadelphia, Pennsylvania. Dr. Cines is rated as a Distinguished provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Blood Clots, and Splenectomy.

Robert A. Brodsky
Elite in Thrombocytopenia
Pathology | Hematology | Oncology
Elite in Thrombocytopenia
Pathology | Hematology | Oncology

Sidney Kimmel Comprehensive Cancer Center

401 North Broadway Street, Weinberg BLDG, Weinberg BLDG, 
Baltimore, MD 
 (55.5 miles away)
Languages Spoken:
English

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kerr's expertise for a condition
ConditionClose
    View All 11 Distinguished Conditions
    View All 32 Advanced Conditions
    View All 87 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile